Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease

Table 4 Social functioning-36 scores in residual symptoms and symptom-free groups

Dimensionality	Residual symptoms	Symptom-free	Control	F	P value
PF	91.31 ± 8.73	92.03 ± 7.62	92.31 ± 8.26	0.81	0.3926
RP	80.01 ± 19.121	89.93 ± 18.93	94.10 ± 12.15	3.90	0.0117
BP	59.00 ± 10.061	86.22 ± 11.13	89.31 ± 14.81	31.24	< 0.0001
GH	61.25 ± 16.121	85.28 ± 15.26	83.15 ± 11.32	30.27	< 0.0001
VT	64.46 ± 17.921	81.30 ± 19.21	90.61 ± 20.13	12.93	< 0.0001
SF	61.53 ± 11.461	79.23 ± 19.73	80.16 ± 17.23	10.25	< 0.0001
RE	57.64 ± 10.112	68.17 ± 23.55	82.72 ± 18.19	11.75	< 0.0001
MH	50.96 ± 13.132	66.21 ± 12.46	89.15 ± 16.28	23.29	< 0.0001

¹Significant difference between residual symptoms and symptom-free groups and control group;

²Significant difference among the three groups. PF: Physical functioning; RP: Role limitations-physical; BP: Bodily pain; GH: General health; VT: Vitality; SF: Social functioning; RE: Role limitations-emotional; MH: Mental health.